Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175565 | SCV000227074 | benign | not specified | 2014-10-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000588731 | SCV000279024 | benign | not provided | 2019-07-03 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Reported in both the heterozygous and homozygous states in unaffected individuals and in individuals with familial Mediterranean fever (Kim et al., 2006; Tomiyama et al., 2008); This variant is associated with the following publications: (PMID: 24965843, 17329916, 22989844, 23166428, 24797171, 24598070, 10854105, 24929125, 20041150, 25073670, 22534884, 26332735, 29017770, 28482392, 29178647, 26537665, 19967574, 18328141, 25261100, 29642170, 26457478, 29526930, 29151129, 24661635, 32199921, 32735870) |
Invitae | RCV001083220 | SCV000629042 | likely benign | Familial Mediterranean fever | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000175565 | SCV000696068 | uncertain significance | not specified | 2022-05-02 | criteria provided, single submitter | clinical testing | Variant summary: MEFV c.329T>C (p.Leu110Pro) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0066 in 247780 control chromosomes, predominantly at a frequency of 0.084 within the East Asian subpopulation in the gnomAD database, including 61 homozygotes. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 4-fold of the estimated maximal expected allele frequency for a pathogenic variant in MEFV causing Familial Mediterranean Fever phenotype (0.022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. However, the variant c.329T>C has also been commonly reported in FMF patients, primarily in the same allele (in cis) with p.E148Q, both in heterozygote and homozygote phases. In addition, multiple publications show lack of cosegregation for the variant and disease (Oshima_2010, Berdeli_2011, and Kim_2007). In Japanese population, the variant's allele frequency is higher in patients than in controls. Case-control studies in Japanese population indicate this variant may associate with increased risk of FMF (OR= 1.78, Migita_2016; OR=4.81, Tsuchiya-Suzuki_2009). Larger case-control studies are needed to validate these findings. At least one functional study demonstrated no damaging effect of this variant (Honda_2021). Three ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign and three ClinVar submitters (evaluation after 2014) cite it as uncertain significance. In 2018, the experts international study group for systemic autoinflammatory diseases (INSAID) reported a validated classification of uncertain significance for the variant (Van Gijn_2018). Based on the data available at this time, it is unknown whether this variant represents a low penetrance mild common pathogenic variant, modifier, or a risk allele. Therefore, this variant was classified as uncertain significance, until additional information becomes available. |
ARUP Laboratories, |
RCV000588731 | SCV000884107 | likely benign | not provided | 2022-02-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001083220 | SCV001277846 | uncertain significance | Familial Mediterranean fever | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Clinical Genetics and Genomics, |
RCV000588731 | SCV001450092 | uncertain significance | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001083220 | SCV001653449 | uncertain significance | Familial Mediterranean fever | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262770 | SCV002543754 | benign | Autoinflammatory syndrome | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001083220 | SCV001462431 | uncertain significance | Familial Mediterranean fever | 2020-01-07 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000588731 | SCV001977937 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000588731 | SCV001979697 | uncertain significance | not provided | no assertion criteria provided | clinical testing |